UnknownPhase 3NCT01872962

Induction Gemcitabine and Cisplatin in Patients With Locoregionally Advanced Nasopharyngeal Carcinoma

Studying Nasopharyngeal carcinoma

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Sun Yat-sen University
Principal Investigator
Jun Ma, M.D.
Sun Yat-Sen University Cancer Center
Intervention
gemcitabine and cisplatin (Induction chemotherapy)(drug)
Enrollment
480 target
Eligibility
18-65 years · All sexes
Timeline
2013 – 2020

Study locations (1)

Collaborators

Fudan University · West China Hospital · Tongji Hospital · Peking University · Zhejiang Cancer Hospital · First People's Hospital of Foshan · Cancer Hospital of Guangxi Medical University · Jiangxi Provincial Cancer Hospital · Xijing hospital of The fourth military medical university · Cancer Hospital of Guizhou Province · Affiliated Cancer Hospital of Shantou University Medical College · Fifth Affiliated Hospital, Sun Yat-Sen University · Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT01872962 on ClinicalTrials.gov

Other trials for Nasopharyngeal carcinoma

Additional recruiting or active studies for the same condition.

See all trials for Nasopharyngeal carcinoma →

← Back to all trials